FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2920229986> ?p ?o ?g. }

• W2920229986 abstract "MALAIVEMBU ILAI CHOORANAM1. The trial drug Malaivembu Ilai Chooranam has been selected for anti diabeticactivity based on strong literary evidence.i) After obtaining guidance for the Head of the department and permission from principal, Government siddha medical college. Pharmacological study was carried out in C.L. Baid Metha college of pharmacy, Thoraipakkam, Chennai.ii) The single drug was prepared as chooranam then purified and stored.2. Phytochemical tests showed the presence of alkaloids, flavanoids, tannin and phytosteroids.3. Rf values were determined by Thin Layer Chromatography.4. Antimicrobial study proved that Malaivembu Ilai Chooranam was an effective anti bacterial agents.5. Bio-Chemical analysis shows the presence of elements like zinc, calcium and Iron (Ferrous).6. Malaivembu Ilai Chooranam at the dose of 2000mg/kg/po did not exhibit any mortality in mice.7. Animal experiments revealed that this drug is effective in controlling blood sugar levels significantly when given in a dose of 500mg bds with water before food.8. Clinical trial showed that Malaivembu Ilai Chooranam is effective in reducing both the fasting and postprandial blood sugar levels. It was done in Arignar Anna Hospitalof Indian medicine, Chennai – 106.9. The statistical analysis also significantly shows the reduction of symptoms like polyuria, tiredness, polydipsia, polyphagia, giddiness and peripheral neuritis.10. The administration of Malaivembu Ilai Chooranam for 48 days did not produce any side effects. Out of 40 patients 33 patients showed better response in reduction at symptoms like polyuria, polydipsia, polyphagia, fatigue and giddiness. Moderate response in peripheral neuritis.11. The trial drug is available at everywhere in all seasons. The preparation and preservation of the trial drug is simple and economical. So it is concluded thatMalaivembu Ilai Chooranam has antidiabetic activity and moderately effective for controlling blood sugar levels.PAAVANA OMUM:The trial drug Paavana Omum has been selected for its antiulcer activity bases on literature evidence.1. Bio- Chemical analysis shows the presence of elements Copper, Magnesium, calcium and Iron (ferric) 26.(i) Copper has ulcer healing property.(ii) Mg – Magnesium Hydroxide that neutralize the HCL.(iii) Ca is in the form of CaCl2 in the stomach. It is a antacid.2. Animal experiments revealed that drug has a ulcer healing property when given in a dose of 500mg bds with water before food.3. Clinical trial showed that Paavana omum is effective.4. The Statistical analysis also significantly shows the reduction of symptoms like epigastric pain, heartburn, regurgitation, nausea, vomiting and abdominal distension.5. The administration of Paavana Omum for 48 days did not produce any side effects.6. Out of 40 patients, 30 patients showed better response in reduction at symptoms like epigastric pain, heartburn, regurgitation, nausea, vomiting, and abdominal distension.7. So it is concluded Paavana Omum has antiulcer activity." @default.
• W2920229986 created "2019-03-11" @default.
• W2920229986 creator A5008792380 @default.
• W2920229986 date "2008-09-01" @default.
• W2920229986 modified "2023-09-26" @default.
• W2920229986 title "A Study on Malaivembu Ilai Chooranam and Paavana Omum" @default.
• W2920229986 hasPublicationYear "2008" @default.
• W2920229986 type Work @default.
• W2920229986 sameAs 2920229986 @default.
• W2920229986 citedByCount "0" @default.
• W2920229986 crossrefType "dissertation" @default.
• W2920229986 hasAuthorship W2920229986A5008792380 @default.
• W2920229986 hasConcept C126322002 @default.
• W2920229986 hasConcept C134018914 @default.
• W2920229986 hasConcept C2779624480 @default.
• W2920229986 hasConcept C2780180277 @default.
• W2920229986 hasConcept C555293320 @default.
• W2920229986 hasConcept C556039675 @default.
• W2920229986 hasConcept C71924100 @default.
• W2920229986 hasConceptScore W2920229986C126322002 @default.
• W2920229986 hasConceptScore W2920229986C134018914 @default.
• W2920229986 hasConceptScore W2920229986C2779624480 @default.
• W2920229986 hasConceptScore W2920229986C2780180277 @default.
• W2920229986 hasConceptScore W2920229986C555293320 @default.
• W2920229986 hasConceptScore W2920229986C556039675 @default.
• W2920229986 hasConceptScore W2920229986C71924100 @default.
• W2920229986 hasLocation W29202299861 @default.
• W2920229986 hasOpenAccess W2920229986 @default.
• W2920229986 hasPrimaryLocation W29202299861 @default.
• W2920229986 hasRelatedWork W2353788167 @default.
• W2920229986 hasRelatedWork W2894930522 @default.
• W2920229986 hasRelatedWork W2904850454 @default.
• W2920229986 hasRelatedWork W2906957262 @default.
• W2920229986 hasRelatedWork W2907537808 @default.
• W2920229986 hasRelatedWork W2914641390 @default.
• W2920229986 hasRelatedWork W2918139493 @default.
• W2920229986 hasRelatedWork W2918724164 @default.
• W2920229986 hasRelatedWork W2921626939 @default.
• W2920229986 hasRelatedWork W2931718888 @default.
• W2920229986 hasRelatedWork W2938589160 @default.
• W2920229986 hasRelatedWork W2940052240 @default.
• W2920229986 hasRelatedWork W2945633535 @default.
• W2920229986 hasRelatedWork W3047294575 @default.
• W2920229986 hasRelatedWork W3047455866 @default.
• W2920229986 hasRelatedWork W3047477800 @default.
• W2920229986 hasRelatedWork W3210952972 @default.
• W2920229986 hasRelatedWork W2186382448 @default.
• W2920229986 hasRelatedWork W2590745659 @default.
• W2920229986 hasRelatedWork W2914494405 @default.
• W2920229986 isParatext "false" @default.
• W2920229986 isRetracted "false" @default.
• W2920229986 magId "2920229986" @default.
• W2920229986 workType "dissertation" @default.